Clinigence Holdings (NUTX) has released an update.
Nutex Health, Inc. and Yorkville mutually agreed to terminate their Pre-Paid Advance Agreement, effectively ending their financial arrangement that allowed Nutex to request advances up to $100 million, which Yorkville would buy at a discount. Nutex Health took an initial $25 million advance, issued 21.4 million shares to Yorkville, and made prepayments to reduce the principal. By January 2024, Nutex had fully paid off the initial advance, and as of mid-February, all obligations under the agreement were ceased without any outstanding advances, notices, shares to be issued, or termination fees.
For further insights into NUTX stock, check out TipRanks’ Stock Analysis page.
